PATENT CLAIM ANALYSIS

Application Number: 16043641
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["424", "452000"]

Abstract:
Provided herein are methods of treating multiple sclerosis with a fumarate, wherein the fumarate is a dialkyl fumarate, a monoalkyl fumarate, a combination of a dialkyl fumarate and a monoalkyl fumarate, a prodrug of monoalkyl fumarate, a deuterated form of any of the foregoing, or a pharmaceutically acceptable salt, clathrate, solvate, tautomer, or stereoisomer of any of the foregoing, or a combination of any of the foregoing. The methods provided herein improve the safety of treatment by informing and monitoring patients undergoing treatment regarding progressive multifocal leukoencephalopathy, and/or by monitoring lymphocyte count.

Claim (Index 326):
The method of  claim 323 , wherein the administering is of 240 mg dimethyl fumarate twice daily orally.

Metadata:
- Claim Count in Document: 255.0
- Percentile: 95.0
- Lexical Diversity: 2.12
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15125612', '15386175', '15248506', '15582913', '15249820']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7069784339356022
- 35 USC 102 Novelty (BERT): 0.5005063881447308
- Combined Prediction Score: 0.6863312293565151
- Mean Citation Score: 216.669098
- Max Citation Score: 243.98125
- Similarity Product: 175.34532318636775

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test